Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PMRS Continues Campaign Against Other Abuse Deterrent Opioid Products

Nov 15 2018

• By Brenda Sandburg

Opioid Oxycodone crushed

Related Content

Not Another Opana: US FDA Panel Rejects PTI’s Remoxy On Intravenous Abuse Concerns

Jun 27 2018

Mallinckrodt's Abuse Deterrent Oxycodone IR Narrowly Wins US FDA Panel Backing

Nov 15 2018

Not Your Typical Response: Oxycodone Sponsor Seeks FDA Hearing On Complete Response Letter

Feb 12 2018

Opioid Dispute Resolution Denied By US FDA In Part Because Of Dueling Requests

Oct 30 2018

Related Companies

Mallinckrodt plc

Cassava Sciences, Inc.

Daiichi Sankyo Co., Ltd.

Inspirion Delivery Technologies LLC

Additional Topics

United States Drug Review FDA Regulation Neurology BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window